NCAB Puts 20% Cap On P01 Budget Raises To Stem Requests Exceeding NCI’s.
Bishop Completes Term As NCAB Chairman; Terms Of Five Extended Awaiting W.H. Action.
UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.
NCI, SAIC To Support Contracts For Molecular Target Labs.
NCAB: An Extraordinary Opportunity For Budgetary Coordination.
Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials.
BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.
Aventis, MediGene In Pact For Development Of Vaccine.
Firm To Study Imaging System As Adjunct To Mammogram.
Techniclone Wins Patent For Tumor Necrosis Therapy.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
- John Burklow replaced by Seana Cranston as NIH chief of staff
